Dialysis Facilities in Newport News, Virginia
8 dialysis facilities found, showing 1 - 8
 RAI - Thimble Shoals-Newport News Chain: Fresenius Medical Care Location: 739 Thimble Shoals Blvd, Newport News, Virginia, 23606 Rating: Phone: (757) 873-1090 |
Davita - Newport News Chain: Davita Location: 711 79th Street, Newport News, Virginia, 23605 Rating: Phone: (757) 245-8090 |
Peninsula Dialysis Center Chain: Davita Location: 716 Denbigh Blvd, Newport News, Virginia, 23608 Rating: Phone: (757) 875-1125 |
RAI - Chesapeake-Newport News Chain: Fresenius Medical Care Location: 225 Chesapeake Avenue, Newport News, Virginia, 23607 Rating: Phone: (757) 247-4080 |
Jefferson Avenue Dialysis Chain: Davita Location: 11234 Jefferson Ave, Newport News, Virginia, 23601 Rating: Phone: (757) 595-6167 |
Zara Dialysis Llc Chain: Davita Location: 11234 Jefferson Ave Ste B, Newport News, Virginia, 23601 Rating: Phone: (757) 595-5469 |
FMC - Denbigh Chain: Fresenius Medical Care Location: 555 Denbigh Blvd, Newport News, Virginia, 23608 Rating: Phone: (757) 898-9391 |
Port Warwick Dialysis Chain: Davita Location: 445 Oriana Road, Newport News, Virginia, 23608 Rating: Not Available Phone: (757) 898-9212 |
News Archive
Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC
Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.
Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints
Vertex Pharmaceuticals Incorporated today announced that treatment with the investigational selective oral JAK3 inhibitor VX-509 in a Phase 2a trial resulted in substantial and statistically significant improvements in multiple measurements of rheumatoid arthritis (RA) activity.
Researchers discover key role of RAP1 gene in obesity
The discovery of an unexpected function for a gene that was associated to another process in the organism might be a solution in search of a problem, a clue to unsuspected connections. That is what has happened with RAP1, a gene that protects telomeres- the ends of chromosomes-after researchers from the Spanish National Cancer Research Centre surprisingly discovered its key role in obesity.
Vienna Declaration signed to support evidence-based drug policy for improving community health
Sandra Roelofs, First Lady of Georgia; George Tsereteli, Georgia's Deputy Chairman of Parliament; and Irakli Giorgobiani, Georgia's Vice Minister of Labour, Health and Social Affairs, today signed the Vienna Declaration, the official declaration of the XVIII International AIDS conference in Vienna, Austria.
Steer clear of allergy triggers when buying gifts for Valentine's Day
Valentine's Day tends to bring out the urge to "spend big" on gifts that will sweep your loved one off their feet. But some gifts can cause allergy and asthma symptoms and should be avoided no matter how much you think they might convey your devotion.
› Verified 3 days ago
Dialysis Facility
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
Medicare Star Ratings
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.